双重介入治疗原发性肝癌的疗效观察

Observation of treating primary hepatic cancer by double interventional therapy

为观察肝脏瘤体内注射32P治疗肝动脉化疗栓塞术后对残留的肝癌组织治疗效果。在肝动脉化疗栓塞术后一周，B超引导下在残留的肝脏肿瘤内注射32P。结果肝脏残留肿瘤组织内注射32P后，可使肿瘤进一步缩小，由术前78．6mm±5．2mm缩至42．3mm±7．3mm，P＜0．01，肿瘤液化、坏死。AFP由675．43±162．65μg／L降至68．12±24．23μg／L，P＜0．01。肝动脉血流速度降低有显著性，P＜0．05。结论肝动脉化疗栓塞术和B超引导下肝脏瘤体内注射32P双重介入治疗原发性肝癌效果显著。

To observe the effect of the treating survival tumour in liver by injecting 32P guided by B type ultrasound after TAE. Results:at the first and third week after double intervention therapy the diameter of tumour in patients with PHC defltaed significantly, P<0 .05. P<0 .01,and there are necrosis caves after treatment.AFP decreased from 675. 43 (before iperation)±162. 65 (after operation)μg/L. peients with PHC s liver artery flowing Velocity decreased significantly form 108.6± 52.5cm/s to 31 .3±10. 96cm/s in the first week and to 36. 15±15. 42cm/s in the third week. P<0. 01 However. at fifth week,revered to lever of that before operation P < 0.05 .Conclution It's a good method to treat PHC with the double interventional therpy.